Novavax COVID-19 jab trialled at King’s CRF approved by UK drugs agency
UK drugs regulator, the Medicine and Healthcare products Regulatory Agency (MHRA) has approved Novavax's Nuvaxovid vaccine, which was trialled at the King's CRF, for use in the UK.
By NIHR Wellcome King's Clinical Research Facility at 16 Feb 2022